ABL Bio Inc. Logo

ABL Bio Inc.

Develops bispecific antibody therapies for oncology and neurodegenerative diseases.

298380 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울 강남구 봉은사로 456 에이비엘바이오빌딩, 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ABL Bio Inc. is a clinical-stage biotechnology company that researches and develops novel antibody therapeutics, primarily focusing on bispecific antibodies. The company's core activities are concentrated in two main therapeutic areas: immuno-oncology and neurodegenerative diseases. For oncology, ABL Bio engineers bispecific antibodies and Antibody-Drug Conjugates (ADCs) designed to enhance anti-tumor immune responses and overcome resistance to existing treatments. In the neurodegenerative field, it utilizes a proprietary platform that enhances the penetration of the blood-brain barrier (BBB) to deliver therapeutics to the central nervous system for diseases like Parkinson's. A pioneer in its field in South Korea, ABL Bio was the first to advance a bispecific antibody platform into clinical trials in the country.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ABL Bio Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-09 00:00
Share Issue/Capital Change
주식매수선택권행사
Korean 43.5 KB
2025-09-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-01 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과)
Korean 16.4 KB
2025-08-26 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.7 KB

Automate Your Workflow. Get a real-time feed of all ABL Bio Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ABL Bio Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Trainers´ House Oyj Logo
Consulting & coaching firm driving growth via leadership, sales & strategy execution.
Finland TRH1V
TRAJANO Logo
Provides strategic consulting and innovative business solutions.
Spain YTRA
Transgene Logo
Developing viral immunotherapies like vaccines and oncolytic viruses to treat solid tumors.
France TNG
TRANS GENIC GROUP INC. Logo
Offers drug discovery CRO services (gene editing, trials) and business investment/consulting.
Japan 2342
True Data Inc. Logo
A big data platform offering consumer purchasing analytics from Japan's largest ID-POS data network.
Japan 4416
Tsubota Laboratory Incorporated Logo
Developing pharmaceuticals and medical devices for ophthalmic and brain diseases.
Japan 4890
Tvardi Therapeutics Inc. Logo
Clinical-stage biopharma developing oral STAT3 inhibitors for fibrotic diseases.
United States of America TVRD
TWOSTONE&Sons Inc. Logo
An engineer platform providing IT talent and marketing services for corporate digital transformation.
Japan 7352
UJU Holding Limited Logo
AI-driven, full-link short-video marketing solutions for enterprises in China.
Hong Kong 1948
unerry,Inc. Logo
Transforms location data into actionable insights for retail and public sectors using AI.
Japan 5034

Talk to a Data Expert

Have a question? We'll get back to you promptly.